SCHEMBL20273673

SCHEMBL20273673

CC/N=C(/c1cccnc1)N(C)C(C)(CC)OC

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP3A4 P08684 2/20 0.43
CYP2C19 P33261 1/20 0.43
ALDH1A1 P00352 3/20 0.38
SMN1; SMN2 Q16637 2/20 0.37
RIPK1 Q13546 1/20 0.36
MAPT P10636 2/20 0.36
L3MBTL1 Q9Y468 1/20 0.36
GFER P55789 1/20 0.36
NPSR1 Q6W5P4 1/20 0.36
LMNA P02545 3/20 0.35
CYP1A2 P05177 1/20 0.35
CYP11B1 P15538 1/20 0.35
CYP11B2 P19099 1/20 0.35
TDP1 Q9NUW8 1/20 0.35
HTT P42858 1/20 0.35
GAA P10253 1/20 0.35
PLOD2 O00469 1/20 0.35
PLOD3 O60568 1/20 0.35
PLOD1 Q02809 1/20 0.35
KMT2A Q03164 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3073776 0.73 CYP2C19 (0.51) CYP3A4CYP2C19ALDH1A1SMN1; SMN2MAPT
SCHEMBL22281477 0.67 CYP3A4 (0.54) CYP3A4CYP2C19ALDH1A1MAPTLMNA
SCHEMBL5056593 0.67 CYP3A4 (0.54) CYP3A4CYP2C19ALDH1A1MAPTLMNA
SCHEMBL3073777 0.64 ALDH1A1 (0.51) CYP3A4CYP2C19ALDH1A1SMN1; SMN2MAPT
SCHEMBL22047112 0.62 MAPT (0.43) CYP3A4CYP2C19ALDH1A1SMN1; SMN2MAPT
SCHEMBL19223914 0.62 LMNA (0.61) CYP3A4ALDH1A1SMN1; SMN2RIPK1L3MBTL1
SCHEMBL8841639 0.62 MLYCD (0.55) CYP3A4CYP2C19ALDH1A1MAPTGFER
SCHEMBL19223885 0.62 LMNA (0.61) CYP3A4ALDH1A1SMN1; SMN2RIPK1L3MBTL1
SCHEMBL14168881 0.61 ALDH1A1 (0.58) CYP3A4CYP2C19ALDH1A1SMN1; SMN2MAPT
SCHEMBL21259802 0.61 KDM4E (0.44) CYP3A4CYP2C19ALDH1A1SMN1; SMN2L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3056207-B1 THERAPEUTIC COMPOUNDS AND RELATED METHODS OF USE OTSUKA PHARMA CO LTD (JP) 2018-06-20 EP disclosed